SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-24-095564
Filing Date
2024-04-15
Accepted
2024-04-15 08:21:55
Documents
2
Group Members
JOSEPH EDELMANPERCEPTIVE LIFE SCIENCES MASTER FUND LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d814552dsc13ga.htm SC 13G/A 58092
2 EX-99.1 d814552dex991.htm EX-99.1 4225
  Complete submission text file 0001193125-24-095564.txt   63916
Mailing Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003
Business Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003 646-205-5300
PERCEPTIVE ADVISORS LLC (Filed by) CIK: 0001224962 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 617-207-8979
Acrivon Therapeutics, Inc. (Subject) CIK: 0001781174 (see all company filings)

IRS No.: 825125532 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-93824 | Film No.: 24843186
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)